New Directions for Sickle Cell Therapy in the Genome Era

New Directions for Sickle Cell Therapy in the Genome Era

Agenda

Wednesday, November 19, 2003
8:30-9:00 a.m. Welcome: Drs. Zerhouni, Collins, Alving and Weatherall
Moderator: Greg Evans
9:00-9:30 a.m. Plenary I: The Pathophysiology of Sickle Cell Disease: State of the Art - Martin Steinberg
9:30-9:50 a.m. Discussion
9:50-10:20 a.m. Break
10:20-10:50 a.m. Plenary II: Therapeutics for Sickle Cell Disease: State of the Art - Elliott Vichinsky
10:50-11:10 a.m. Discussion
11:10-11:40 a.m. Plenary III:  Therapeutic Implications of Phenotypic Diversity - Orah Platt
11:40-12:00 p.m. Discussion
12:00-1:00 p.m. Lunch
Moderator: Karen Hofman
1:00-1:30 p.m. Plenary IV: Hemoglobin Switching - George Stamatoyannopoulos
1:30-1:50 p.m. Discussion
1:50-2:20 p.m. Plenary V: Gene Transfer - Michel Sadelain
2:20-2:40 p.m. Discussion
2:40-3:00 p.m. Break
3:00-3:30 p.m. Plenary VI: Small Molecule/Chemical Genomics Approaches - John Haley
3:30-3:50 p.m. Discussion
3:50-4:20 p.m. Plenary VII: Historical, Cultural, and Social Context of Clinical Research in Sickle Cell Disease - Vanessa Northington Gamble
4:20-4:40 p.m. Discussion
4:40-5:00 p.m. Instructions to Working Groups - Alan Guttmacher
5:00-6:00 p.m.

Reception

Thursday, November 20, 2003
8:30-10:00 p.m. Concurrent Working Groups- Session A
  • Therapeutic Implications of Phenotypic Diversity - Kwaku Ohene-Frempong
  • Hemoglobin Switching - Susan Perrine
  • Gene Transfer - Punam Malik
  • Small Molecule/Chemical Genomics Approaches - Christopher Austin
  • Historical, Cultural, and Social Context of Clinical Research - Lennette Benjamin
10:00-10:30 p.m. Break
10:30-12:00 p.m. Concurrent Working Groups - Session A (Continued)
12:00-1:00 p.m. Lunch
1:00-2:30 p.m. Concurrent Working Groups - Session B
  • Therapeutic Implications of Phenotypic Diversity - Swee-Lay Thein
  • Hemoglobin Switching - George Dover
  • Gene Transfer - David Bodine
  • Small Molecule/Chemical Genomics Approaches - Alan Schechter
  • Historical, Cultural, and Social Context of Clinical Research - Joseph Telfair
2:30-3:00 p.m. Break
3:00-4:30 p.m. Concurrent Working Groups - Session B (Continued)
7:00-9:30 p.m.

Group Dinner - Remarks by Sir David Weatherall

Friday, November 21, 2003
Moderator: Alan Guttmacher
8:00-8:30 a.m. Presentation/Discussion - Working Groups on Therapeutic Implications of Phenotypic Diversity
8:30-9:00 a.m. Presentation/Discussion - Working Groups on Hemoglobin Switching
9:00-9:30 a.m. Presentation/Discussion - Working Groups on Gene Transfer
9:30-10:00 a.m. Presentation/Discussion - Working Groups on Small Molecule/Chemical Genomics Approaches
10:00-10:30 a.m. Break
10:30-11:00 a.m. Presentation/Discussion - Working Groups on Historical, Cultural and Social Context of Clinical Research in Sickle Cell Disease
11:00-1:00 p.m. Where to go from here - led by Drs. Weatherall and Collins

Top of page

Last Reviewed: November 19, 2012